期刊文献+

CD166、Ki67在食管癌中的表达及其意义 被引量:3

Expression of CD166 and Ki67 protein in esophageal cancer and its significance
下载PDF
导出
摘要 目的研究CD166及Ki67在食管癌中的表达,探讨其临床意义。方法采用免疫组化法检测CD166和Ki67在食管癌中的表达,分析其与临床及病理各参数的相关性。结果食管癌组织中CD166蛋白表达的总阳性率为76.19%。其表达率在性别和年龄上无明显区别,但是在肿瘤浸润、分化程度以及淋巴结转移方面有着明显的差异。CD166蛋白表达与Ki67蛋白表达一致性一般。结论 CD166和Ki67的表达与食管癌的恶性程度以及侵袭、转移程度相关。 Objective To investigate the expression of CD166 and Ki67 protein in esophageal cancer,and to analyze its clinical significance.Methods CD166 and Ki67 protein expression were evaluated in the tissues of 46 human esophageal cancer by using immunohistochemistry.The relationship between theirs clinical and pathological parameters was analyzed.Results The total positive rate of CD166 protein in the tissues of esophageal cancer was 76.19%.The result showed that there was no significant difference of expression rate between gender and age,but has significant difference between primary tumor invasion,differentiation and metastasis of lymphnodes.Consistency of CD166 and Ki67 protein expression is comparatively ordinary.Conclusion Expressions of CD166 and Ki67 were related to the degree of malignancy,invasion and metastasis of esophageal cancer.
机构地区 解放军第 解放军第
出处 《临床军医杂志》 CAS 2012年第5期1003-1005,共3页 Clinical Journal of Medical Officers
基金 杭州市医药卫生科技计划项目(编号2009B087)
关键词 食管癌 CD166 KI67 esophageal cancer CD166 Ki67
  • 相关文献

参考文献9

  • 1王国清,魏文强,乔友林.食管癌筛查和早诊早治的实践与经验[J].中国肿瘤,2010,19(1):4-8. 被引量:45
  • 2Chang JC, Li X, Wong H, et al. Therapeutic resistance and tumor-initiation: Molecular pathways involved in breast cancer stem cell self-renewal[J]. J Clin Oncol, 2007,25 (18S) :528 - 540.
  • 3Phillips TM,Mcbr Idew H,Pajonk F. The response of CD24( =/low)/ CIM4+ breast cancer-initiating cells to radiation[J]. J Nail Cancer Inst, 2006, 98 (24) : 1777 - 1785.
  • 4Calanresec, Popple Tonh, Koca KM, et al. A perivascular niche for brain tumor stem cells [ J ]. Cancer Cell, 2007, 11 ( 1 ) : 69 - 82.
  • 5Stoner GD, Gupta A. Etiology and chemoprevention of esophageal squamous cell carcainoma [ J ]. Carcinogenesis, 2001, 22 (11) :1737 -1746.
  • 6Jezierska A, Matysiak W, Motyl T. ALCAM /CD166 protects breast cancer cells against apoptosis and autophagy [ J ]. Med Sci Monit, 2006, 12 (8) : 263 -273.
  • 7van Kempen LC, van den Oorcl JJ, van Muijen GN, et al. Acti- vated leukocyte cell adhesion molecule/CD166, a marker of tumor pro88ion in primary mali'nant melanoma of the skin [J]. Am J Pathol,2000,1S6 (3) :769 -774.
  • 8Verma A, Shukla NK, Deo SV, et al. MEMD/ALCAM: a po- tential marker for tumor invasion and nodal metastasis in esopha- geal squamous cell carcinoma[ J]. Oncology, 2005, 68 (46) : 462 - 470.
  • 9Zheng JN, Ma TX, Cao JY, et al. Knockdown of Ki67 by small interfering RNA leads to inhibition of proliferation and induction of apoptosis in human renal carcinoma cells[ J]. Life Science, 2006,78 (7) :724 - 729.

二级参考文献9

共引文献44

同被引文献32

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2Puafiski A, Piarek A, Krzakowski M. Crizotinib in the treatment of non-small-cell lung carcinoma [ J ]. Contemp Oncol, 2012, 16 (6) :480-484.
  • 3Eldeeb H, Reza S. Northampton outcome for first and second line chemotherapy in non-small cell lung cancer:5 years data [J]. Contemp Oncol (Pozn) ,2012,16 (5) :420-423.
  • 4Ebben JD, Treisman DM, Zorrniak M, et al. The cancer stem cell paradigm:a new Understanding of tumor development and treat- ment[J]. Expert Opin Ther Targets,2010,14(6) :621-632.
  • 5Nishino M,Cardarella S,Jackman DM,et al. RECIST 1.1 in NSCLC patients with EGFR mutations treated with EGFR tymsine kinase in- hibitors:comparison with RECIST 1.0[ J ]. AIR Am J Roentgenol, 2013,201(1) :64-71.
  • 6Burkhard T, Mayordomo E, Winzer K.I, et al. Cytoplasmic over ex- pression of ALCAM is prognostic of disease progression in breast cancer[ J]. J Clin Patho1,2006,59 (4) :403-409.
  • 7Chittcti BR, Bethel M, Kacena MA, CD166 and regulation of hem- atopoiesis [ J ]. Curr Ooin Hematol. 2013.20 ( 4 ) : 273-280.
  • 8Ishigami S, Ueno S, Arigami T, et al. Clinical implication of CD166 expression.in gastric cancer [ J ]. J Surg Oneol, 2011,103 ( 1 ) : 5% 61.
  • 9Steven W, Johnson,James P, et al. Cisplatin and its analogues [J]. Cancer,2001,15 (6) : 380 -382.
  • 10Xiang-Yang Zhao,Lin Chen,Yu-Hong Li,Qian Xu.PlexinA1 expression in gastric carcinoma and its relationship with tumor angiogenesis and proliferation[J].World Journal of Gastroenterology,2007,13(48):6558-6561. 被引量:8

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部